Article
CD9, a tetraspanin target for cancer therapy?
18 Feb 2021
Abstract excerpt
In the present minireview, we intend to provide a brief history of the field of CD9 involvement in oncogenesis and in the metastatic process of cancer, considering its potential value as a tumor-associated antigenic target. Over the years, CD9 has been identified as a favorable prognostic marker or predictor of metastatic potential depending on the cancer type. To understand its implications in cancer beside its...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
